Trials / Conditions / Stage IV Renal Pelvis and Ureter Cancer AJCC v8
Stage IV Renal Pelvis and Ureter Cancer AJCC v8
4 registered clinical trials studyying Stage IV Renal Pelvis and Ureter Cancer AJCC v8 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bl NCT06764095 | Mayo Clinic | Phase 4 |
| Active Not Recruiting | Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in NCT05092958 | National Cancer Institute (NCI) | Phase 3 |
| Terminated | Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary NCT04398368 | Mayo Clinic | Phase 2 |
| Active Not Recruiting | Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourin NCT02496208 | National Cancer Institute (NCI) | Phase 1 |